Bio-Functionalized Magnetic Nanoparticles for the Immunoassay of C-Reactive Protein and Procalcitonin in Cervicovaginal Secretions of Pregnant Women with Preterm Prelabor Rupture of Membranes to Predict Early-Onset Neonatal Sepsis

References

• The American College of Obstetricians and Gynecologists. prelabor rupture of membranes: acog practice bulletin, number 217. Obstet Gynecol. 2020;135(3):e80–e97. doi:10.1097/AOG.0000000000003700.
   PubMed Web of Science ®Google Scholar
• Ramsey PS, Lieman JM, Brumfield CG, et al. Chorioamnionitis increases neonatal morbidity in pregnancies complicated by preterm premature rupture of membranes. Am J Obstet Gynecol. 2005;192(4):1162–1166. doi:10.1016/j.ajog.2004.11.035
   PubMed Web of Science ®Google Scholar
• Beck C, Gallagher K, Taylor LA, et al. Chorioamnionitis and risk for maternal and neonatal sepsis: a systematic review and meta-analysis. Obstet Gynecol. 2021;137(6):1007–1022. doi:10.1097/AOG.0000000000004377
   PubMed Web of Science ®Google Scholar
• Committee on Obstetric Practice. The American College of Obstetricians and Gynecologists. Committee Opinion No. 712: intrapartum management of intraamniotic infection. Obstet Gynecol. 2017;130(2):e95–e101. doi:10.1097/AOG.0000000000002236.
   PubMed Web of Science ®Google Scholar
• Polin RA, Papile L-A, Baley JE; Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129(5):1006–1015. doi:10.1542/peds.2012-0541
   PubMed Web of Science ®Google Scholar
• Chauhan N, Tiwari S, Jain U. Potential biomarkers for effective screening of neonatal sepsis infections: an overview. Microb Pathog. 2017;107:234–242. doi:10.1016/j.micpath.2017.03.042
   PubMed Web of Science ®Google Scholar
• Balayan S, Chauhan N, Chandra R, Kuchhal NK, Jain U. Recent advances in developing biosensing based platforms for neonatal sepsis. Biosens Bioelectron. 2020;169:112552. doi:10.1016/j.bios.2020.112552
   PubMed Web of Science ®Google Scholar
• Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. doi:10.3389/fimmu.2018.00754
   PubMed Web of Science ®Google Scholar
• Gilbert DN. Use of plasma procalcitonin levels as an adjunct to clinical microbiology. J Clin Microbiol. 2010;48(7):2325–2329. doi:10.1128/JCM.00655-10
   PubMed Web of Science ®Google Scholar
• Mangogna A, Agostinis C, Ricci G, et al. Overview of procalcitonin in pregnancy and in pre-eclampsia. Clin Exp Immunol. 2019;198(1):37–46. doi:10.1111/cei.13311
   PubMed Web of Science ®Google Scholar
• Ryu JA, Yang JH, Lee D, et al. Clinical usefulness of procalcitonin and C-reactive protein as outcome predictors in critically ill patients with severe sepsis and septic shock. PLoS One. 2015;10(9):e0138150. doi:10.1371/journal.pone.0138150
   PubMed Web of Science ®Google Scholar
• Samsudin I, Vasikaran SD. Clinical utility and measurement of procalcitonin. Clin Biochem Rev. 2017;38(2):59–68.
   PubMedGoogle Scholar
• Chen CY, Hwu YM, Chen CP, et al. Quantitative analysis of total β-subunit of human chorionic gonadotropin concentration in urine by immunomagnetic reduction to assist in the diagnosis of ectopic pregnancy. Int J Nanomedicine. 2015;10:2475–2483. doi:10.2147/IJN.S81201
   PubMed Web of Science ®Google Scholar
• Chen CY, Chang CC, Lin CW. Clinical application of immunomagnetic reduction for quantitative measurement of insulin-like growth factor binding protein-1 in the prediction of pregnant women with preterm premature rupture of membranes. Clin Chim Acta. 2015;438:337–341. doi:10.1016/j.cca.2014.09.023
   PubMed Web of Science ®Google Scholar
• Wong CH, Chen CP, Chang CC, et al. Bio-functionalized magnetic nanoparticles for the immunoassay of fetal fibronectin: a feasibility study for the prediction of preterm birth. Sci Rep. 2017;7(1):42461. doi:10.1038/srep42461
   PubMed Web of Science ®Google Scholar
• Chen CY, Hwu YM, Weng YW, et al. Clinical application of immunomagnetic reduction for quantitative analysis of beta-subunit of human chorionic gonadotropin in blastocyst culture media to differentiate embryo quality. Clin Chim Acta. 2019;491:46–51. doi:10.1016/j.cca.2019.01.012
   PubMed Web of Science ®Google Scholar
• Shim SS, Romero R, Jun JK, et al. C-reactive protein concentration in vaginal fluid as a marker for intra-amniotic inflammation/infection in preterm premature rupture of membranes. J Matern Fetal Neonatal Med. 2005;18(6):417–422. doi:10.1080/14786430500362231
   PubMed Web of Science ®Google Scholar
• Torbé A, Czajka R. Are vaginal fluid procalcitonin levels useful for the prediction of subclinial infection in patients with preterm premature rupture of membranes? J Obstet Gynaecol Res. 2005;31(5):464–470. doi:10.1111/j.1447-0756.2005.00321.x
   PubMed Web of Science ®Google Scholar
• Kuyumcuoglu U, Kangal K, Guzel AI, et al. Clinical significance of procalcitonin in cervico-vaginal secretions of women with preterm rupture of membranes. Clin Exp Obstet Gynecol. 2010;37(4):319–321.
   PubMed Web of Science ®Google Scholar
• Klingenberg C, Kornelisse RF, Buonocore G, et al. Culture-negative early-onset neonatal sepsis - at the crossroad between efficient sepsis care and antimicrobial stewardship. Front Pediatr. 2018;6:285. doi:10.3389/fped.2018.00285
   PubMed Web of Science ®Google Scholar
• Tita AT, Andrews WW. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol. 2010;37(2):339–354. doi:10.1016/j.clp.2010.02.003
   PubMed Web of Science ®Google Scholar
• Holzman C, Lin X, Senagore P, Chung H. Histologic chorioamnionitis and preterm delivery. Am J Epidemiol. 2007;166(7):786–794. doi:10.1093/aje/kwm168
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu Y, Du C, et al. Diagnostic value of amniotic fluid inflammatory biomarkers for subclinical chorioamnionitis. Int J Gynaecol Obstet. 2016;134(2):160–164. doi:10.1016/j.ijgo.2016.01.007
   PubMed Web of Science ®Google Scholar
• Marchocki Z, Vinturache A, Collins K, et al. Amniotic fluid C-reactive protein as a predictor of infection in caesarean section: a feasibility study. Sci Rep. 2018;8(1):6372. doi:10.1038/s41598-018-24569-8
   PubMed Web of Science ®Google Scholar
• Dulay AT, Buhimschi IA, Zhao G, et al. Compartmentalization of acute phase reactants interleukin-6, C-reactive protein and procalcitonin as biomarkers of intra-amniotic infection and chorioamnionitis. Cytokine. 2015;76(2):236–243. doi:10.1016/j.cyto.2015.04.014
   PubMed Web of Science ®Google Scholar
• Horinouchi T, Yoshizato T, Kozuma Y, et al. Prediction of histological chorioamnionitis and neonatal and infantile outcomes using procalcitonin in the umbilical cord blood and amniotic fluid at birth. J Obstet Gynaecol Res. 2018;44(4):630–636. doi:10.1111/jog.13573
   PubMed Web of Science ®Google Scholar
• Schneider HG, Lam QT. Procalcitonin for the clinical laboratory: a review. Pathology. 2007;39(4):383–390. doi:10.1080/00313020701444564
   PubMed Web of Science ®Google Scholar
• Struck J, Strebelow M, Tietz S, et al. Method for the selective measurement of amino-terminal variants of procalcitonin. Clin Chem. 2009;55(9):1672–1679. doi:10.1373/clinchem.2008.123018
   PubMed Web of Science ®Google Scholar
• Weglöhner W, Struck J, Fischer-Schulz C, et al. Isolation and characterization of serum procalcitonin from patients with sepsis. Peptides. 2001;22(12):2099–2103. doi:10.1016/s0196-9781(01)00541-1
   PubMed Web of Science ®Google Scholar
• Kenny AJ, Booth AG, George SG, et al. Dipeptidyl peptidase IV, a kidney brush-border serine peptidase. Biochem J. 1976;157(1):169–182. doi:10.1042/bj1570169
   PubMed Web of Science ®Google Scholar
• Itoh K, Suzuki T. Antibody-guided selection using capture-sandwich ELISA. Methods Mol Biol. 2002;178:195–199. doi:10.1385/1-59259-240-6:195
   PubMedGoogle Scholar
• Blizniukov OP, Kozmin LD, Falikova VV, et al. Aggregation of C-reactive protein in solutions at acid pH. Biofizika. 2003;48(5):844–852.
   PubMed Web of Science ®Google Scholar
• Hammond DJ Jr, Singh SK, Thompson JA, et al. Identification of acidic pH-dependent ligands of pentameric C-reactive protein. J Biol Chem. 2010;285:36235–36244. doi:10.1074/jbc.M110.142026
   PubMed Web of Science ®Google Scholar
• Musilova I, Kacerovsky M, Stepan M, et al. Maternal serum C-reactive protein concentration and intra-amniotic inflammation in women with preterm prelabor rupture of membranes. PLoS One. 2017;12:e0182731. doi:10.1371/journal.pone.0182731
   PubMed Web of Science ®Google Scholar
• Asadi N, Faraji A, Keshavarzi A, et al. Predictive value of procalcitonin, C-reactive protein, and white blood cells for chorioamnionitis among women with preterm premature rupture of membranes. Int J Gynaecol Obstet. 2019;147(1):83–88. doi:10.1002/ijgo.12907
   PubMed Web of Science ®Google Scholar
• Alvarez M, Lechuga LM. Microcantilever-based platforms as biosensing tools. Analyst. 2010;135(5):827–836. doi:10.1039/b908503n
   PubMed Web of Science ®Google Scholar
• Huang KW, Yang SY, Hong YW, et al. Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles. Int J Nanomedicine. 2012;7:1991–1996. doi:10.2147/IJN.S28245
   PubMed Web of Science ®Google Scholar
• Chang CH, Lai ZX, Lin HL, et al. Use of immunomagnetic reduction for C-reactive protein assay in clinical samples. Int J Nanomedicine. 2012;7:4335–4340. doi:10.2147/IJN.S31030
   PubMed Web of Science ®Google Scholar